Clinical trial

A Study to Explore the Existence of Horizontal Transmission of the RIX4414…

NCT00396630 · GlaxoSmithKline, Industry · Completed

Key facts

NCT number NCT00396630
Title A Study to Explore the Existence of Horizontal Transmission of the RIX4414 Vaccine Strain Between Twins Within a Family.
Official title A Phase IIIb, Randomized, Double-Blind, Placebo-Controlled Study to Explore the Existence of Horizontal Transmission of the RIX4414 Vaccine Strain Between Twins Within a Family.
Lead sponsor GlaxoSmithKline, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Infections, Rotavirus
Intervention type Biological
Interventions Rotarix, Placebo
Enrollment 200
Start date Jan 23, 2007
Primary completion Jan 23, 2008
Completion Feb 13, 2008
First posted Nov 7, 2006
Last update posted Feb 6, 2018
Countries Dominican Republic

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies